Press Releases

PHILADELPHIA, PA, UNITED STATES - Oct 12, 2016 - ERT, a leading provider of high-quality patient data collection solutions for use in clinical drug development, today announced the appointment of Dr. Prakriteswar Santikary to Chief Data Officer. Dr. Santikary will be responsible for advancing the vision and implementation of ERT’s broadening data and reporting architecture strategy. 

“Dr. Santikary brings a wealth of experience that will immediately enhance ERT’s capabilities in delivering high quality, data-driven solutions to meet the needs of our growing client base. We are excited to have him as a part of the ERT team,” said Andrea Valente, Chief Development Officer, ERT.

Dr. Santikary has over 20 years of experience in successfully delivering enterprise data management, business intelligence, data integration, predictive analytics, and master data management and big data solutions for a wide range of industries, including former roles as Director of Software Development and Head of Data Engineering at EBay, VP of Engineering at Zeta Interactive and Chief Data Architect at Sunovion Pharmaceuticals and PNC Bank.

“I’m thrilled to join ERT and to contribute to the team’s success at delivering the highest quality data-driven products by using data, analytics, science and business intelligence reporting solutions that give trial sponsors and CROs the information they need to move ahead quickly and with confidence,” said Dr. Santikary. 

For more information on ERT’s leadership team, visit https://www.ert.com/about-us/ert-leadership/.

About ERT

ERT is a leading provider of high-quality patient data collection solutions for use in clinical drug development. ERT delivers a combination of technology, services and clinical consulting that increase the accuracy and reliability of patient data and improve the efficiency of the clinical development process. ERT delivers widely deployed solutions in centralized Cardiac Safety, Respiratory, and electronic Clinical Outcome Assessments (eCOA) - which includes patient-, clinician-, observer- and performance-reported outcomes - and cloud-based analytics and performance metrics. By efficiently integrating these solutions through a system built upon a scientific and regulatory foundation, ERT collects, analyzes and delivers safety and efficacy data critical to the approval, labeling and reimbursement of pharmaceutical products. For more information, see www.ert.com. Join ERT on LinkedIn, Twitter, YouTube and  Facebook.